Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland.
Department of Biochemistry and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland.
Clin Chim Acta. 2017 Aug;471:95-100. doi: 10.1016/j.cca.2017.05.023. Epub 2017 May 17.
The urea cycle disorder carbamoyl phosphate synthetase I deficiency is an important differential diagnosis in the encephalopathic neonate. This intoxication type inborn error of metabolism often leads to neonatal death or severe and irreversible damage of the central nervous system, even despite appropriate treatment. Timely diagnosis is crucial, but can be difficult on routine metabolite level. Here, we report ten neonates from eight families (finally) diagnosed with CPS1 deficiency at three tertiary metabolic centres. In seven of them the laboratory findings were dominated by significantly elevated urinary 3-methylglutaconic acid levels which complicated the diagnostic process. Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect.
尿素循环障碍中氨甲酰磷酸合成酶 I 缺乏症是脑病新生儿的重要鉴别诊断。这种中毒型先天性代谢错误通常导致新生儿死亡或中枢神经系统严重且不可逆转的损伤,即使给予适当的治疗。及时诊断至关重要,但在常规代谢物水平上可能难以诊断。在此,我们报告了在三个三级代谢中心最终诊断为 CPS1 缺乏症的 8 个家庭中的 10 例新生儿。其中 7 例的实验室检查结果以显著升高的尿 3-甲基戊烯二酸水平为特征,这使诊断过程复杂化。我们的发现对于尿素循环障碍患者的鉴别诊断非常重要,并且还拓宽了与 3-甲基戊烯二酸尿相关的高氨血症的鉴别诊断范围,以前仅在 TMEM70 和 SERAC1 缺陷中报告过。